Page 52 - Read Online

Akabane et al. Hepatoma Res 2023;9:29 https://dx.doi.org/10.20517/2394-5079.2023.45 Page 7 of 9

Availability of Data and Materials
Not applicable.

Financial Support and Sponsorship
None.

Conflicts of Interest
All authors declared that there are no conflicts of interest.

Ethical Approval and Consent to Participate
Not applicable.

Consent for Publication
Not applicable.

Copyright
© The Author(s) 2023.

REFERENCES
1. Banales JM, Cardinale V, Carpino G, et al. Expert consensus document: Cholangiocarcinoma: current knowledge and future
perspectives consensus statement from the European network for the study of cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol
Hepatol 2016;13:261-80. DOI PubMed
2. Bertuccio P, Malvezzi M, Carioli G, et al. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J Hepatol
2019;71:104-14. DOI
3. Mauro E, Ferrer-Fàbrega J, Sauri T, et al. New challenges in the management of cholangiocarcinoma: the role of liver transplantation,
locoregional therapies, and systemic therapy. Cancers 2023;15:1244. DOI PubMed PMC
4. Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol
2014;60:1268-89. DOI
5. Khan SA, Davidson BR, Goldin RD, et al; British society of gastroenterology. guidelines for the diagnosis and treatment of
cholangiocarcinoma: an update. Gut 2012;61:1657-69. DOI
6. Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev
Clin Oncol 2018;15:95-111. DOI
7. Sapisochin G, de Lope CR, Gastaca M, et al. Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients
undergoing liver transplantation: a Spanish matched cohort multicenter study. Ann Surg 2014;259:944-52. DOI PubMed
8. Sapisochin G, Facciuto M, Rubbia-Brandt L, et al; iCCA International Consortium. Liver transplantation for "very early" intrahepatic
cholangiocarcinoma: international retrospective study supporting a prospective assessment. Hepatology 2016;64:1178-88. DOI
PubMed
9. Lunsford KE, Javle M, Heyne K, et al; Methodist–MD Anderson Joint Cholangiocarcinoma Collaborative Committee (MMAJCCC).
Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.
Lancet Gastroenterol Hepatol 2018;3:337-48. DOI
10. Pichlmayr R. Is there a place for liver grafting for malignancy? Transplant Proc 1988;20:478-482. PubMed
11. Pichlmayr R, Weimann A, Tusch G, et al. Indications and role of liver transplantation for malignant tumors. Oncologist 1997;2:164-
170. PubMed
12. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008;371:838-51. DOI PubMed PMC
13. Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepatology 2011;54:173-84. DOI PubMed PMC
14. Bergquist A, von Seth E. Epidemiology of cholangiocarcinoma. Best Pract Res Clin Gastroenterol 2015;29:221-32. DOI PubMed
15. Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? J Hepatol 2012;57:69-76. DOI
PubMed PMC
16. Welzel TM, Mellemkjaer L, Gloria G, et al. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide
case-control study. Int J Cancer 2007;120:638-41. DOI
17. Li M, Li J, Li P, et al. Hepatitis B virus infection increases the risk of cholangiocarcinoma: a meta-analysis and systematic review. J
Gastroenterol Hepatol 2012;27:1561-8. DOI
18. Kang Y, Lee JM, Kim SH, Han JK, Choi BI. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-
enhanced MR images. Radiology 2012;264:751-60. DOI PubMed
19. Kodali S, Shetty A, Shekhar S, Victor DW, Ghobrial RM. Management of intrahepatic cholangiocarcinoma. J Clin Med 2021;10:2368.